1.
Product Overview
2.
Research Methodology
3. Impact
of COVID-19 on Global Plasma Fractionation Market
4. Executive Summary
5. Global Plasma
Fractionation Market Outlook
5.1.
Market Size & Forecast
5.1.1. By Value &
Volume
5.2.
Market Share & Forecast
5.2.1.
By Product
5.2.1.1.1.
Coagulation Factors (Factor VIII, Factor IX,
Prothrombin,
Fibrinogen, Others)
5.2.1.1.2.
Immunoglobins (IgGs)
5.2.1.1.3.
Protease Inhibitor (Alpha-1-Antitrypsin,
C1-inhibitor)
5.2.1.1.4.
Anticoagulants(antithrombin)
5.2.1.1.5.
Albumin
5.2.2.
By Method (Cohn Cold Fractioning Process, Chromatography,
Cryoprecipitation, Molecular Imprinting, Salt Diafiltration Process, Others)
5.2.3.
By Plasma Source (Blood Test, Plasmapheresis)
5.2.4.
By Test (NAT-testing, ELISA, Screening Test)
5.2.5.
By Donor (Recovered Plasma, Source Plasma)
5.2.6.
By Application (Neurology, Immunology, Hematology, Others)
5.2.7.
By End-User (Hospitals and Clinics, Clinical Research Laboratories, Others)
5.2.8.
By Company (2021)
5.2.9.
By Region
5.3.
Market Attractiveness Index
6. Asia-Pacific Plasma
Fractionation Market Outlook
6.1.
Market Size & Forecast
6.1.1. By Value &
Volume
6.2.
Market Share & Forecast
6.2.1. By Product
6.2.2. By Method
6.2.3. By Plasma Source
6.2.4. By Test
6.2.5. By Donor
6.2.6. By Application
6.2.7. By End-User
6.2.8. By Country
6.3.
Market Attractiveness Index
6.4.
Asia-Pacific: Country Analysis
6.4.1. China Plasma
Fractionation Market Outlook
6.4.1.1.
Market Size & Forecast
6.4.1.1.1.
By Value
6.4.1.2.
Market Share & Forecast
6.4.1.2.1.
By Product
6.4.1.2.2.
By Method
6.4.1.2.3.
By Plasma Source
6.4.1.2.4.
By Test
6.4.1.2.5.
By Donor
6.4.1.2.6.
By Application
6.4.1.2.7.
By End-User
6.4.2. India Plasma
Fractionation Market Outlook
6.4.2.1.
Market Size & Forecast
6.4.2.1.1.
By Value
6.4.2.2.
Market Share & Forecast
6.4.2.2.1.
By Product
6.4.2.2.2.
By Method
6.4.2.2.3.
By Plasma Source
6.4.2.2.4.
By Test
6.4.2.2.5.
By Donor
6.4.2.2.6.
By Application
6.4.2.2.7.
By End-User
6.4.3. Japan Plasma
Fractionation Market Outlook
6.4.3.1.
Market Size & Forecast
6.4.3.1.1.
By Value
6.4.3.2.
Market Share & Forecast
6.4.3.2.1.
By Product
6.4.3.2.2.
By Method
6.4.3.2.3.
By Plasma Source
6.4.3.2.4.
By Test
6.4.3.2.5.
By Donor
6.4.3.2.6.
By Application
6.4.3.2.7.
By End-User
6.4.4. South Korea Plasma
Fractionation Market Outlook
6.4.4.1.
Market Size & Forecast
6.4.4.1.1.
By Value
6.4.4.2.
Market Share & Forecast
6.4.4.2.1.
By Product
6.4.4.2.2.
By Method
6.4.4.2.3.
By Plasma Source
6.4.4.2.4.
By Test
6.4.4.2.5.
By Donor
6.4.4.2.6.
By Application
6.4.4.2.7.
By End-User
6.4.5. Singapore Plasma
Fractionation Market Outlook
6.4.5.1.
Market Size & Forecast
6.4.5.1.1.
By Value
6.4.5.2.
Market Share & Forecast
6.4.5.2.1.
By Product
6.4.5.2.2.
By Method
6.4.5.2.3.
By Plasma Source
6.4.5.2.4.
By Test
6.4.5.2.5.
By Donor
6.4.5.2.6.
By Application
6.4.5.2.7.
By End-User
6.4.6. Australia Plasma
Fractionation Market Outlook
6.4.6.1.
Market Size & Forecast
6.4.6.1.1.
By Value
6.4.6.2.
Market Share & Forecast
6.4.6.2.1.
By Product
6.4.6.2.2.
By Method
6.4.6.2.3.
By Plasma Source
6.4.6.2.4.
By Test
6.4.6.2.5.
By Donor
6.4.6.2.6.
By Application
6.4.6.2.7.
By End-User
7. Europe Plasma
Fractionation Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value &
Volume
7.2.
Market Share & Forecast
7.2.1.
By Product
7.2.2.
By Method
7.2.3.
By Plasma Source
7.2.4.
By Test
7.2.5.
By Donor
7.2.6.
By Application
7.2.7.
By End-User
7.2.8. By Country
7.3.
Market Attractiveness Index
7.4.
Europe: Country Analysis
7.4.1. France Plasma
Fractionation Market Outlook
7.4.1.1.
Market Size & Forecast
7.4.1.1.1.
By Value
7.4.1.2.
Market Share & Forecast
7.4.1.2.1.
By Product
7.4.1.2.2.
By Method
7.4.1.2.3.
By Plasma Source
7.4.1.2.4.
By Test
7.4.1.2.5.
By Donor
7.4.1.2.6.
By Application
7.4.1.2.7.
By End-User
7.4.2. Germany Plasma
Fractionation Market Outlook
7.4.2.1.
Market Size & Forecast
7.4.2.1.1.
By Value
7.4.2.2.
Market Share & Forecast
7.4.2.2.1.
By Product
7.4.2.2.2.
By Method
7.4.2.2.3.
By Plasma Source
7.4.2.2.4.
By Test
7.4.2.2.5.
By Donor
7.4.2.2.6.
By Application
7.4.2.2.7.
By End-User
7.4.3. United Kingdom
Plasma Fractionation Market Outlook
7.4.3.1.
Market Size & Forecast
7.4.3.1.1.
By Value
7.4.3.2.
Market Share & Forecast
7.4.3.2.1.
By Product
7.4.3.2.2.
By Method
7.4.3.2.3.
By Plasma Source
7.4.3.2.4.
By Test
7.4.3.2.5.
By Donor
7.4.3.2.6.
By Application
7.4.3.2.7.
By End-User
7.4.4. Italy Plasma
Fractionation Market Outlook
7.4.4.1.
Market Size & Forecast
7.4.4.1.1.
By Value
7.4.4.2.
Market Share & Forecast
7.4.4.2.1.
By Product
7.4.4.2.2.
By Method
7.4.4.2.3.
By Plasma Source
7.4.4.2.4.
By Test
7.4.4.2.5.
By Donor
7.4.4.2.6.
By Application
7.4.4.2.7.
By End-User
8. North America Plasma
Fractionation Market Outlook
8.1.
Market Size & Forecast
8.1.1. By Value &
Volume
8.2.
Market Share & Forecast
8.2.1.
By Product
8.2.2.
By Method
8.2.3.
By Plasma Source
8.2.4.
By Test
8.2.5.
By Donor
8.2.6.
By Application
8.2.7.
By End-User
8.2.8. By Country
8.3.
Market Attractiveness Index
8.4.
North America: Country Analysis
8.4.1. United States Plasma
Fractionation Market Outlook
8.4.1.1.
Market Size & Forecast
8.4.1.1.1.
By Value
8.4.1.2.
Market Share & Forecast
8.4.1.2.1.
By Product
8.4.1.2.2.
By Method
8.4.1.2.3.
By Plasma Source
8.4.1.2.4.
By Test
8.4.1.2.5.
By Donor
8.4.1.2.6.
By Application
8.4.1.2.7.
By End-User
8.4.2. Mexico Plasma
Fractionation Market Outlook
8.4.2.1.
Market Size & Forecast
8.4.2.1.1.
By Value
8.4.2.2.
Market Share & Forecast
8.4.2.2.1.
By Product
8.4.2.2.2.
By Method
8.4.2.2.3.
By Plasma Source
8.4.2.2.4.
By Test
8.4.2.2.5.
By Donor
8.4.2.2.6.
By Application
8.4.2.2.7.
By End-User
8.4.3. Canada Plasma
Fractionation Market Outlook
8.4.3.1.
Market Size & Forecast
8.4.3.1.1.
By Value
8.4.3.2.
Market Share & Forecast
8.4.3.2.1.
By Product
8.4.3.2.2.
By Method
8.4.3.2.3.
By Plasma Source
8.4.3.2.4.
By Test
8.4.3.2.5.
By Donor
8.4.3.2.6.
By Application
8.4.3.2.7.
By End-User
9. South America Plasma
Fractionation Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value &
Volume
9.2.
Market Share & Forecast
9.2.1.
By Product
9.2.2.
By Method
9.2.3.
By Plasma Source
9.2.4.
By Test
9.2.5.
By Donor
9.2.6.
By Application
9.2.7.
By End-User
9.2.8. By Country
9.3.
Market Attractiveness Index
9.4.
South America: Country Analysis
9.4.1. Brazil Plasma
Fractionation Market Outlook
9.4.1.1.
Market Size & Forecast
9.4.1.1.1.
By Value
9.4.1.2.
Market Share & Forecast
9.4.1.2.1.
By Product
9.4.1.2.2.
By Method
9.4.1.2.3.
By Plasma Source
9.4.1.2.4.
By Test
9.4.1.2.5.
By Donor
9.4.1.2.6.
By Application
9.4.1.2.7.
By End-User
9.4.2. Argentina Plasma
Fractionation Market Outlook
9.4.2.1.
Market Size & Forecast